Multicenter prospective study of erlotinib in advanced non-small-cell lung cancer (NSCLC) patients with epidermal growth factor receptor (EGFR) mutations

被引：0
|
作者：
Cardenal, Felipe [2 ]
Moran, Teresa [1 ]
Queralt, Cristina [1 ]
Porta, Ruth [3 ]
Camps, Carlos [4 ]
Majem, Margarita [5 ]
Lopez-Vivanco, Guillermo [6 ]
Isla, Dolores [7 ]
Provencio, Mariano [8 ]
Sanchez, Jose Javier [9 ]
Taron, Miquel [1 ]
Rosell, Rafael [1 ]
机构：
[1] Hosp Badalona Germans Trias & Pujol, Inst Catala Oncol, Badalona, Spain
[2] Hosp Duran & Reynals, Catalan Inst Oncol, Bellvitge, Spain
[3] Hosp Trueta, Girona, Spain
[4] Hosp Gen Valencia, Valencia, Spain
[5] Hosp Santa Creu & Sant Pau, Barcelona, Spain
[6] Hosp Cruces, Cruces Baracaldo, Spain
[7] Hosp Lozano Blesa, Zaragoza, Spain
[8] Hosp Puerta de Hierro, Madrid, Spain
[9] Autonomous Univ Madrid, E-28049 Madrid, Spain
来源：
JOURNAL OF THORACIC ONCOLOGY | 2009年 / 4卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S324 / S325
页数：2
相关论文
共 50 条
  • [21] Erlotinib as first-line treatment of European non-small-cell lung cancer (NSCLC) patients (pts.) with epidermal growth factor receptor (EGFR) activating mutations (mut plus )
    Petruzelka, Lubos
    LUNG CANCER, 2012, 77 : S25 - S25
  • [22] A histology-based algorithm in the molecular diagnosis of mutations of the epidermal growth factor receptor (EGFR)-in non-small-cell lung cancer (NSCLC)
    Popper H.
    Wrba F.
    Gruber-Mösenbacher U.
    Hulla W.
    Pirker R.
    Hilbe W.
    Studnicka M.
    Mohn-Staudner A.
    Ploner F.
    memo - Magazine of European Medical Oncology, 2011, 4 (4) : 248 - 253
  • [23] First-line erlotinib in stage IV non-small-cell lung cancer (NSCLC) patients (P) with mutations in the tyrosine kinase (TK) domain of the epidermal growth factor receptor (EGFR)
    Massuti, Bartomeu
    Reguart, Noemi
    Vivanco, Guillermo Lopez
    Provencio, Mariano
    Isla, Dolores
    Camps, Carlos
    Ares, Luis Paz
    Pradas, Anna
    Taron, Miquel
    Rosell, Rafael
    ANNALS OF ONCOLOGY, 2006, 17 : 216 - 216
  • [24] Somatic mutations of the epidermal growth factor receptor and non-small-cell lung cancer
    Zhang, Xiaozhu
    Chang, Alex
    JOURNAL OF MEDICAL GENETICS, 2007, 44 (03) : 166 - 172
  • [25] CUSTOMIZING ERLOTINIB IN METASTATIC NON-SMALL-CELL LUNG CANCER (NSCLC) PATIENTS (P) HARBORING EGFR MUTATIONS
    Sirera, R.
    Catot, S.
    Gonzalez-Larriba, J. L.
    Bover, I.
    Alonso, G.
    Valdivia, J.
    Ibeas, R.
    Lianes, P.
    Martinez del Prado, P.
    Rosell, R.
    ANNALS OF ONCOLOGY, 2008, 19 : 90 - 90
  • [26] Erlotinib Vs Chemotherapy (CT) in Advanced Non-Small-Cell Lung Cancer (NSCLC) Patients (p) With Epidermal Growth Factor Receptor (EGFR) Activating Mutations - the EURTAC Phase II Randomized Trial Interim Results
    De Marinis, F.
    Rosell, R.
    Vergnenegre, A.
    Massuti, B.
    Felip, E.
    Gervais, R.
    Cardenal, F.
    Garcia-Gomez, R.
    Taron, M.
    Paz-Ares, L.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S597 - S597
  • [27] Population based study of the prevalence of epidermal growth factor receptor (EGFR) mutations in non-small cell lung cancer (NSCLC)
    Skov, B. G.
    Hogdall, E.
    Clementsen, P.
    Krasnik, M.
    Larsen, K. R.
    Sorensen, J. B.
    Mellemgaard, A.
    APMIS, 2012, 120 : 14 - 14
  • [28] Phase II trial of erlotinib in patients with advanced non-small-cell lung cancer harboring epidermal growth factor receptor mutations: additive analysis of pharmacokinetics
    Kohei Motoshima
    Yoichi Nakamura
    Kazumi Sano
    Yoji Ikegami
    Takaya Ikeda
    Kosuke Mizoguchi
    Shinnosuke Takemoto
    Minoru Fukuda
    Seiji Nagashima
    Tetsuya Iida
    Kazuhiro Tsukamoto
    Shigeru Kohno
    Cancer Chemotherapy and Pharmacology, 2013, 72 : 1299 - 1304
  • [29] Phase II trial of erlotinib in patients with advanced non-small-cell lung cancer harboring epidermal growth factor receptor mutations: additive analysis of pharmacokinetics
    Motoshima, Kohei
    Nakamura, Yoichi
    Sano, Kazumi
    Ikegami, Yoji
    Ikeda, Takaya
    Mizoguchi, Kosuke
    Takemoto, Shinnosuke
    Fukuda, Minoru
    Nagashima, Seiji
    Iida, Tetsuya
    Tsukamoto, Kazuhiro
    Kohno, Shigeru
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 72 (06) : 1299 - 1304
  • [30] Epidermal Growth Factor Receptor Mutations in 510 Finnish Non-Small-Cell Lung Cancer Patients
    Maki-Nevala, Satu
    Ronty, Mikko
    Morel, Mike
    Gomez, Maria
    Dawson, Zoe
    Sarhadi, Virinder Kaur
    Telaranta-Keerie, Aino
    Knuuttila, Aija
    Knuutila, Sakari
    JOURNAL OF THORACIC ONCOLOGY, 2014, 9 (06) : 886 - 891
12345